GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Simpson-Golabi-Behmel syndrome, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm, squamous cell lung carcinoma	Recruiting	Phase 1	2024-06-25		NCT03198546

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First Affiliated Hospital, Sun Yat-Sen University	113
Guangdong Zhaotai InVivo Biomedicine Co. Ltd.	4
Hunan Zhaotai Yongren Medical Innovation Co. Ltd.	3
Second Affiliated Hospital of Guangzhou Medical University	70

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Sun Yat-sen University	Guangzhou	China	2
The second Affiliated Hospital of Guangzhou Medical University	Guangzhou	China	26